Skip to content

News Archives

 

Neurodyn Cognition Inc. Appoints new Director and Executive Chairman

  Neurodyn Cognition Inc. Appoints new Director and Executive Chairman

Neurodyn Cognition Inc. (NCI)has announced the appointment of Anthony Giovinazzo as a director and Executive Chairman of the Company.  NCI is focused on the development of Memogain, a prodrug of an approved Alzheimer’s therapy with significantly improved safety and efficacy. Giovinazzo has
over 25 years of experience in the biotech industry and has been the recipient of a number of industry honours and awards.
















 





 





 





 





 





 





 





Scroll To Top